AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (December 21, 2004). doi:10.1152/ajpendo.00361.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/E1047    most recent
00361.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corbould, A.
Right arrow Articles by Dunaif, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corbould, A.
Right arrow Articles by Dunaif, A.
Submitted on August 9, 2004
Accepted on December 10, 2004

Insulin Resistance in the Skeletal Muscle of Women with Polycystic Ovary Syndrome Involves both Intrinsic and Acquired Defects in Insulin Signaling

Anne Corbould1, Young-Bum Kim2, Jack F. Youngren3, Celia Pender3, Barbara B. Kahn2, Anna Lee4, and Andrea Dunaif5*

1 Division of Women's Health, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
2 Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
3 Division of Diabetes and Endocrine Research, University of California, Mount Zion Medical Center, San Francisco, CA, USA
4 Division of Women's Health, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA; Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
5 Division of Women's Health, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA; Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, The Feinberg School of Medicine, Chicago, IL, USA

* To whom correspondence should be addressed. E-mail: a-dunaif{at}northwestern.edu.

Insulin resistance in polycystic ovary syndrome (PCOS) is due to a post-binding defect in signaling that persists in cultured skin fibroblasts and is associated with constitutive serine phosphorylation of the insulin receptor (IR). Cultured skeletal muscle from obese women with PCOS and age- and body mass index (BMI)-matched control women (n = 10/group) was studied to determine whether signaling defects observed in this tissue in vivo were intrinsic or acquired. Basal and insulin-stimulated glucose transport and glucose transporter 1 (GLUT1) abundance were significantly increased in cultured myotubes from women with PCOS. Neither IR {beta}-subunit abundance and tyrosine autophosphorylation nor insulin receptor substrate (IRS)-1-associated phosphatidylinositol (PI) 3-kinase activity differed in the two groups. However, IRS-1 protein abundance was significantly increased in PCOS resulting in significantly decreased PI 3-kinase activity when normalized for IRS-1. Phosphorylation of IRS-1 on Ser312, a key regulatory site, was significantly increased in PCOS, which may have contributed to this signaling defect. Insulin signaling via IRS-2 was also decreased in myotubes from women with PCOS. In summary, decreased insulin-stimulated glucose uptake in PCOS skeletal muscle in vivo is an acquired defect. Nevertheless, there are intrinsic abnormalities in glucose transport and insulin signaling in myotubes from affected women, including increased phosphorylation of IRS-1 Ser312, that may confer increased susceptibility to insulin resistance-inducing factors in the in vivo environment. These abnormalities differ from those reported in other insulin resistant states consistent with the hypothesis that PCOS is a genetically unique disorder conferring an increased risk for type 2 diabetes.




This article has been cited by other articles:


Home page
Hum ReprodHome page
J. J. Kim, Y. M. Choi, M. A. Hong, S. S. Hwang, S. H. Yoon, S. J. Chae, B. C. Jee, S. Y. Ku, J. G. Kim, and S. Y. Moon
Phosphatidylinositol 3-kinase p85{alpha} regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome
Hum. Reprod., May 1, 2009; 24(5): 1184 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. F. Svendsen, L. Nilas, K. Norgaard, J.-E. B. Jensen, and S. Madsbad
Obesity, body composition and metabolic disturbances in polycystic ovary syndrome
Hum. Reprod., September 1, 2008; 23(9): 2113 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Franks, J. Stark, and K. Hardy
Follicle dynamics and anovulation in polycystic ovary syndrome
Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Chakrabarty and M. Nagamani
Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries
Reproductive Sciences, March 1, 2008; 15(3): 274 - 284.
[Abstract] [PDF]


Home page
DiabetesHome page
K. Hojlund, D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frosig, H. Beck-Nielsen, and J. F.P. Wojtaszewski
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Diabetes, February 1, 2008; 57(2): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Skov, D. Glintborg, S. Knudsen, T. Jensen, T. A. Kruse, Q. Tan, K. Brusgaard, H. Beck-Nielsen, and K. Hojlund
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
Diabetes, September 1, 2007; 56(9): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
X. Ma, L. Fan, Y. Meng, Z. Hou, Y.-D. Mao, W. Wang, W. Ding, and J.-Y. Liu
Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome
Mol. Hum. Reprod., August 1, 2007; 13(8): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk
Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome
Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. A. Beckman, A. B. Goldfine, A. Dunaif, M. Gerhard-Herman, and M. A. Creager
Endothelial Function Varies According to Insulin Resistance Disease Type
Diabetes Care, May 1, 2007; 30(5): 1226 - 1232.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. S. Legro
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
JAMA, February 7, 2007; 297(5): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Morino, K. F. Petersen, and G. I. Shulman
Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
Diabetes, December 1, 2006; 55(Supplement_2): S9 - S15.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F Gonzalez, N S Rote, J Minium, and J P Kirwan
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-{alpha} release in obese women with polycystic ovary syndrome.
J. Endocrinol., March 1, 2006; 188(3): 521 - 529.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.